Your browser doesn't support javascript.
loading
Effects of luseogliflozin on estimated plasma volume in patients with heart failure with preserved ejection fraction.
Nakashima, Mitsutaka; Miyoshi, Toru; Ejiri, Kentaro; Kihara, Hajime; Hata, Yoshiki; Nagano, Toshihiko; Takaishi, Atsushi; Toda, Hironobu; Nanba, Seiji; Nakamura, Yoichi; Akagi, Satoshi; Sakuragi, Satoru; Minagawa, Taro; Kawai, Yusuke; Nishii, Nobuhiro; Fuke, Soichiro; Yoshikawa, Masaki; Nakamura, Kazufumi; Ito, Hiroshi.
Afiliación
  • Nakashima M; Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
  • Miyoshi T; Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
  • Ejiri K; Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
  • Kihara H; Department of Internal Medicine, Tamano City Hospital, Okayama, Japan.
  • Hata Y; Department of Internal Medicine, Kihara Cardiovascular Clinic, Asahikawa, Japan.
  • Nagano T; Department of Cardiology, Minamino Cardiovascular Hospital, Hachioji, Japan.
  • Takaishi A; Department of Internal Medicine, Iwasa Hospital, Gifu, Japan.
  • Toda H; Department of Cardiology, Mitoyo General Hospital, Kanonji, Japan.
  • Nanba S; Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
  • Nakamura Y; Department of Internal Medicine, Okayama East Neurosurgery Hospital, Okayama, Japan.
  • Akagi S; Department of Cardiology, Okayama Rosai Hospital, Okayama, Japan.
  • Sakuragi S; Department of Cardiovascular Medicine, Specified Clinic of Soyokaze CardioVascular Medicine and Diabetes Care, Matsuyama, Japan.
  • Minagawa T; Department of Internal Medicine, Akaiwa Medical Association Hospital, Okayama, Japan.
  • Kawai Y; Department of Cardiovascular Medicine, Iwakuni Clinical Center, Iwakuni, Japan.
  • Nishii N; Department of Internal Medicine, Minagawa Cardiovascular Clinic, Gifu, Japan.
  • Fuke S; Department of Cardiovascular Medicine, Okayama City Hospital, Okayama, Japan.
  • Yoshikawa M; Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
  • Nakamura K; Department of Internal Medicine, Yoshinaga Hospital, Bizen, Japan.
  • Ito H; Department of Cardiovascular Medicine, Japanese Red Cross Okayama Hospital, Okayama, Japan.
ESC Heart Fail ; 9(1): 712-720, 2022 02.
Article en En | MEDLINE | ID: mdl-35267246
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: ESC Heart Fail Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: ESC Heart Fail Año: 2022 Tipo del documento: Article País de afiliación: Japón